Health Care & Life Sciences » Pharmaceuticals | Hunan Er-Kang Pharmaceutical Co. Ltd.

Hunan Er-Kang Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Hunan Er-Kang Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
China AMC Dividend Fund
32,058,038
2.96%
0
1.36%
12/31/2017
32,051,267
2.96%
-7,890,320
5.36%
12/31/2017
25,743,104
2.38%
-13,876,128
4.29%
12/31/2017
China AMC Income Fund
5,148,727
0.48%
-720,000
0.73%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
1,676,979
0.16%
0
0%
07/31/2018
1,381,200
0.13%
0
0.01%
12/31/2017
799,966
0.07%
-200,000
1.14%
12/31/2017
500,332
0.05%
153,800
0.19%
12/31/2017
Da Cheng SZSE Grow 40 Index ETF
147,204
0.01%
-38,900
0.51%
12/31/2017
102,200
0.01%
-13,415,318
0.06%
12/31/2017

About Hunan Er-Kang Pharmaceutical Co.

View Profile
Address
Liuyang Economic & Development Zone
Changsha Hunan 410331
China
Employees -
Website http://www.hnerkang.com
Updated 07/08/2019
Hunan Er-Kang Pharmaceutical Co., Ltd. engages in the research and development, production and sale of pharmaceutical products. It offers pharmaceutical excipients, active pharmaceutical ingredients (API) and pharmaceutical preparation. The pharmaceutical excipients produce glycerol, medicinal alcohol, propylene glycol, medicinal sodium hydroxide and medical sucrose.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.